Advanced Search (OLGA)

Gene: GPR183 (G protein-coupled receptor 183) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

GPR183

Name:

G protein-coupled receptor 183

RGD ID:

1346200

HGNC Page

HGNC:3128

Description:

Enables G protein-coupled receptor activity and oxysterol binding activity. Involved in several processes, including positive regulation of B cell proliferation; positive regulation of ERK1 and ERK2 cascade; and regulation of astrocyte chemotaxis. Located in nucleoplasm and plasma membrane.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

EBI2; EBV-induced G-protein coupled receptor 2; Epstein-Barr virus induced gene 2 (lymphocyte-specific G protein-coupled receptor); epstein-Barr virus-induced G-protein coupled receptor 2; G-protein coupled receptor 183; hEBI2

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Related Pseudogenes:

CCR12P

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	13	99,294,539 - 99,307,399 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	13	99,294,539 - 99,307,399 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	13	99,946,793 - 99,959,653 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	13	98,744,790 - 98,757,695 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	13	98,744,790 - 98,757,695	NCBI
Celera	13	80,790,353 - 80,803,314 (-)	NCBI		Celera
Cytogenetic Map	13	q32.3	NCBI
HuRef	13	80,541,169 - 80,554,130 (-)	NCBI		HuRef
CHM1_1	13	99,916,965 - 99,929,926 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	13	98,504,775 - 98,517,640 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
GPR183	Human	Anal Atresia, Hypospadias, and Penoscrotal Inversion		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Anal atresia more ...	ClinVar	PMID:31690835
GPR183	Human	holoprosencephaly		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Lobar holoprosencephaly	ClinVar
GPR183	Human	holoprosencephaly 5		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Holoprosencephaly 5	ClinVar	PMID:17274816 more ...
GPR183	Human	holoprosencephaly 5		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Holoprosencephaly 5	ClinVar	PMID:19177455 more ...

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
GPR183	Human	adult T-cell leukemia/lymphoma		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:26437031
GPR183	Human	IgA glomerulonephritis		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:25133636

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
GPR183	Human	1,2-dimethylhydrazine	increases expression	ISO	Gpr183 (Mus musculus)	6480464	1 and 2-Dimethylhydrazine results in increased expression of GPR183 mRNA	CTD	PMID:22206623
GPR183	Human	17beta-estradiol	multiple interactions	EXP		6480464	[Estradiol co-treated with Norethindrone Acetate] results in decreased expression of GPR183 mRNA	CTD	PMID:22217510
GPR183	Human	17beta-estradiol	increases expression	EXP		6480464	Estradiol results in increased expression of GPR183 mRNA	CTD	PMID:31614463
GPR183	Human	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		6480464	2 more ...	CTD	PMID:19095052
GPR183	Human	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	Gpr183 (Mus musculus)	6480464	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GPR183 mRNA	CTD	PMID:25975270
GPR183	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	Gpr183 (Rattus norvegicus)	6480464	Tetrachlorodibenzodioxin results in increased expression of GPR183 mRNA	CTD	PMID:34747641
GPR183	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	Gpr183 (Mus musculus)	6480464	Tetrachlorodibenzodioxin results in increased expression of GPR183 mRNA	CTD	PMID:26290441
GPR183	Human	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	Gpr183 (Mus musculus)	6480464	2 more ...	CTD	PMID:38648751
GPR183	Human	2-hydroxypropanoic acid	increases expression	EXP		6480464	Lactic Acid results in increased expression of GPR183 mRNA	CTD	PMID:30851411
GPR183	Human	4-hydroxynon-2-enal	increases expression	ISO	Gpr183 (Mus musculus)	6480464	4-hydroxy-2-nonenal results in increased expression of GPR183 mRNA	CTD	PMID:19191707
GPR183	Human	4-hydroxyphenyl retinamide	decreases expression	ISO	Gpr183 (Mus musculus)	6480464	Fenretinide results in decreased expression of GPR183 mRNA	CTD	PMID:28973697
GPR183	Human	acetamide	increases expression	ISO	Gpr183 (Rattus norvegicus)	6480464	acetamide results in increased expression of GPR183 mRNA	CTD	PMID:31881176
GPR183	Human	albendazole	multiple interactions	EXP		6480464	[Ivermectin co-treated with Albendazole] results in decreased expression of GPR183 mRNA	CTD	PMID:16861626
GPR183	Human	alpha-Zearalanol	increases expression	ISO	Gpr183 (Rattus norvegicus)	6480464	Zeranol results in increased expression of GPR183 mRNA	CTD	PMID:35163327
GPR183	Human	antirheumatic drug	decreases expression	EXP		6480464	Antirheumatic Agents results in decreased expression of GPR183 mRNA	CTD	PMID:24449571
GPR183	Human	arotinoid acid	multiple interactions	EXP		6480464	[4-(2-(5 more ...	CTD	PMID:34480604
GPR183	Human	arsenous acid	increases expression	EXP		6480464	Arsenic Trioxide results in increased expression of GPR183 mRNA	CTD	PMID:15761015
GPR183	Human	benzo[a]pyrene	increases expression	EXP		6480464	Benzo(a)pyrene results in increased expression of GPR183 mRNA	CTD	PMID:20064835
GPR183	Human	benzo[a]pyrene	decreases methylation	EXP		6480464	Benzo(a)pyrene results in decreased methylation of GPR183 5' UTR and Benzo(a)pyrene results in decreased methylation of GPR183 promoter	CTD	PMID:27901495
GPR183	Human	benzo[a]pyrene	multiple interactions	ISO	Gpr183 (Mus musculus)	6480464	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of GPR183 mRNA] and Benzo(a)pyrene promotes the reaction [AHR protein binds to GPR183 promoter]	CTD	PMID:19654925 and PMID:22228805
GPR183	Human	benzo[a]pyrene	increases methylation	ISO	Gpr183 (Mus musculus)	6480464	Benzo(a)pyrene results in increased methylation of GPR183 3' UTR and Benzo(a)pyrene results in increased methylation of GPR183 exon	CTD	PMID:27901495
GPR183	Human	benzo[a]pyrene	decreases expression	ISO	Gpr183 (Mus musculus)	6480464	Benzo(a)pyrene results in decreased expression of GPR183 mRNA	CTD	PMID:21569818
GPR183	Human	bisphenol A	decreases expression	ISO	Gpr183 (Rattus norvegicus)	6480464	bisphenol A results in decreased expression of GPR183 mRNA	CTD	PMID:25181051 and PMID:34947998
GPR183	Human	bisphenol A	affects methylation	EXP		6480464	bisphenol A affects the methylation of GPR183 gene	CTD	PMID:31601247
GPR183	Human	bisphenol A	multiple interactions	EXP		6480464	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of GPR183 gene	CTD	PMID:31601247
GPR183	Human	buta-1,3-diene	decreases expression	ISO	Gpr183 (Mus musculus)	6480464	1 and 3-butadiene results in decreased expression of GPR183 mRNA	CTD	PMID:29038090
GPR183	Human	butyric acid	decreases expression	EXP		6480464	Butyric Acid results in decreased expression of GPR183 mRNA	CTD	PMID:33770205
GPR183	Human	cadmium atom	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPR183 mRNA	CTD	PMID:35301059
GPR183	Human	cadmium dichloride	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPR183 mRNA	CTD	PMID:35301059
GPR183	Human	cannabidiol	decreases expression	ISO	Gpr183 (Mus musculus)	6480464	Cannabidiol results in decreased expression of GPR183 mRNA	CTD	PMID:21542829
GPR183	Human	carbon nanotube	increases expression	ISO	Gpr183 (Mus musculus)	6480464	Nanotubes and Carbon results in increased expression of GPR183 mRNA	CTD	PMID:25554681
GPR183	Human	carbon nanotube	decreases expression	ISO	Gpr183 (Mus musculus)	6480464	Nanotubes and Carbon results in decreased expression of GPR183 mRNA	CTD	PMID:25926378
GPR183	Human	CHIR 99021	multiple interactions	EXP		6480464	[4-(2-(5 more ...	CTD	PMID:34480604
GPR183	Human	chloroprene	decreases expression	ISO	Gpr183 (Mus musculus)	6480464	Chloroprene results in decreased expression of GPR183 mRNA	CTD	PMID:23125180
GPR183	Human	cisplatin	increases expression	EXP		6480464	Cisplatin results in increased expression of GPR183 mRNA	CTD	PMID:27594783
GPR183	Human	cortisol	multiple interactions	EXP		6480464	[4-(2-(5 more ...	CTD	PMID:34480604
GPR183	Human	crocidolite asbestos	decreases expression	ISO	Gpr183 (Mus musculus)	6480464	Asbestos and Crocidolite results in decreased expression of GPR183 mRNA	CTD	PMID:29279043
GPR183	Human	Cuprizon	increases expression	ISO	Gpr183 (Rattus norvegicus)	6480464	Cuprizone results in increased expression of GPR183 mRNA	CTD	PMID:27523638
GPR183	Human	diarsenic trioxide	increases expression	EXP		6480464	Arsenic Trioxide results in increased expression of GPR183 mRNA	CTD	PMID:15761015
GPR183	Human	dimethylarsinic acid	multiple interactions	ISO	Gpr183 (Mus musculus)	6480464	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR183 mRNA	CTD	PMID:34876320
GPR183	Human	diquat	decreases expression	ISO	Gpr183 (Mus musculus)	6480464	Diquat results in decreased expression of GPR183 mRNA	CTD	PMID:36851058
GPR183	Human	doxorubicin	decreases expression	EXP		6480464	Doxorubicin results in decreased expression of GPR183 mRNA	CTD	PMID:29803840
GPR183	Human	entinostat	decreases expression	EXP		6480464	entinostat results in decreased expression of GPR183 mRNA	CTD	PMID:33770205
GPR183	Human	ethyl methanesulfonate	decreases expression	EXP		6480464	Ethyl Methanesulfonate results in decreased expression of GPR183 mRNA	CTD	PMID:23649840
GPR183	Human	ferric oxide	increases expression	ISO	Gpr183 (Mus musculus)	6480464	ferric oxide analog results in increased expression of GPR183 mRNA	CTD	PMID:24525745
GPR183	Human	fulvestrant	multiple interactions	EXP		6480464	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of GPR183 gene	CTD	PMID:31601247
GPR183	Human	furan	increases expression	ISO	Gpr183 (Rattus norvegicus)	6480464	furan results in increased expression of GPR183 mRNA	CTD	PMID:27387713
GPR183	Human	HC toxin	decreases expression	EXP		6480464	HC toxin results in decreased expression of GPR183 mRNA	CTD	PMID:33770205
GPR183	Human	irinotecan	increases expression	EXP		6480464	Irinotecan metabolite results in increased expression of GPR183 mRNA and Irinotecan results in increased expression of GPR183 mRNA	CTD	PMID:15956246
GPR183	Human	ivermectin	multiple interactions	EXP		6480464	[Ivermectin co-treated with Albendazole] results in decreased expression of GPR183 mRNA	CTD	PMID:16861626
GPR183	Human	L-ascorbic acid	multiple interactions	EXP		6480464	[[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPR183 mRNA	CTD	PMID:34480604
GPR183	Human	L-ascorbic acid 2-phosphate	multiple interactions	EXP		6480464	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPR183 mRNA	CTD	PMID:34480604
GPR183	Human	lead diacetate	increases expression	ISO	Gpr183 (Rattus norvegicus)	6480464	lead acetate results in increased expression of GPR183 mRNA	CTD	PMID:22641619
GPR183	Human	lipopolysaccharide	decreases expression	ISO	Gpr183 (Mus musculus)	6480464	Lipopolysaccharides results in decreased expression of GPR183 mRNA	CTD	PMID:25890327
GPR183	Human	lipopolysaccharide	multiple interactions	EXP		6480464	[S-(1 more ...	CTD	PMID:18192897 and PMID:35811015
GPR183	Human	methotrexate	decreases expression	EXP		6480464	Methotrexate results in decreased expression of GPR183 mRNA	CTD	PMID:17400583
GPR183	Human	methyl methanesulfonate	decreases expression	EXP		6480464	Methyl Methanesulfonate results in decreased expression of GPR183 mRNA	CTD	PMID:23649840
GPR183	Human	methylarsonic acid	multiple interactions	ISO	Gpr183 (Mus musculus)	6480464	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR183 mRNA	CTD	PMID:34876320
GPR183	Human	methylisothiazolinone	increases expression	EXP		6480464	2-methyl-4-isothiazolin-3-one results in increased expression of GPR183 mRNA	CTD	PMID:31629900
GPR183	Human	mocetinostat	decreases expression	EXP		6480464	mocetinostat results in decreased expression of GPR183 mRNA	CTD	PMID:33770205
GPR183	Human	Muraglitazar	decreases expression	ISO	Gpr183 (Rattus norvegicus)	6480464	muraglitazar results in decreased expression of GPR183 mRNA	CTD	PMID:21515302
GPR183	Human	nickel atom	increases expression	EXP		6480464	Nickel results in increased expression of GPR183 mRNA	CTD	PMID:25583101
GPR183	Human	ozone	multiple interactions	ISO	Gpr183 (Mus musculus)	6480464	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GPR183 mRNA	CTD	PMID:34911549
GPR183	Human	ozone	multiple interactions	EXP		6480464	[Air Pollutants results in increased abundance of Ozone] which affects the expression of GPR183 mRNA	CTD	PMID:35430440
GPR183	Human	panobinostat	decreases expression	EXP		6480464	Panobinostat results in decreased expression of GPR183 mRNA	CTD	PMID:33770205
GPR183	Human	paracetamol	affects expression	ISO	Gpr183 (Mus musculus)	6480464	Acetaminophen affects the expression of GPR183 mRNA	CTD	PMID:17562736
GPR183	Human	pioglitazone	decreases expression	EXP		6480464	Pioglitazone results in decreased expression of GPR183 mRNA	CTD	PMID:30031879
GPR183	Human	rac-lactic acid	increases expression	EXP		6480464	Lactic Acid results in increased expression of GPR183 mRNA	CTD	PMID:30851411
GPR183	Human	rosuvastatin calcium	multiple interactions	EXP		6480464	Lipopolysaccharides inhibits the reaction [Rosuvastatin Calcium results in increased expression of GPR183 mRNA]	CTD	PMID:18192897
GPR183	Human	rosuvastatin calcium	increases expression	EXP		6480464	Rosuvastatin Calcium results in increased expression of GPR183 mRNA	CTD	PMID:18192897
GPR183	Human	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		6480464	[S-(1 more ...	CTD	PMID:35811015
GPR183	Human	SB 431542	multiple interactions	EXP		6480464	[LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of GPR183 mRNA	CTD	PMID:34480604
GPR183	Human	sodium arsenate	multiple interactions	ISO	Gpr183 (Mus musculus)	6480464	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR183 mRNA	CTD	PMID:34876320
GPR183	Human	sodium arsenite	decreases expression	EXP		6480464	sodium arsenite results in decreased expression of GPR183 mRNA	CTD	PMID:38568856
GPR183	Human	sodium arsenite	multiple interactions	ISO	Gpr183 (Mus musculus)	6480464	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GPR183 mRNA	CTD	PMID:34876320
GPR183	Human	sunitinib	decreases expression	EXP		6480464	Sunitinib results in decreased expression of GPR183 mRNA	CTD	PMID:31533062
GPR183	Human	tacedinaline	decreases expression	EXP		6480464	tacedinaline results in decreased expression of GPR183 mRNA	CTD	PMID:33770205
GPR183	Human	Tesaglitazar	decreases expression	ISO	Gpr183 (Rattus norvegicus)	6480464	tesaglitazar results in decreased expression of GPR183 mRNA	CTD	PMID:21515302
GPR183	Human	thioacetamide	increases expression	ISO	Gpr183 (Rattus norvegicus)	6480464	Thioacetamide results in increased expression of GPR183 mRNA	CTD	PMID:34492290
GPR183	Human	titanium dioxide	increases expression	ISO	Gpr183 (Rattus norvegicus)	6480464	titanium dioxide results in increased expression of GPR183 mRNA	CTD	PMID:30012374
GPR183	Human	trichloroethene	decreases expression	ISO	Gpr183 (Rattus norvegicus)	6480464	Trichloroethylene results in decreased expression of GPR183 mRNA	CTD	PMID:33387578
GPR183	Human	trichostatin A	decreases expression	EXP		6480464	trichostatin A results in decreased expression of GPR183 mRNA	CTD	PMID:33770205
GPR183	Human	triclosan	decreases expression	EXP		6480464	Triclosan results in decreased expression of GPR183 mRNA	CTD	PMID:30510588
GPR183	Human	trimellitic anhydride	increases expression	ISO	Gpr183 (Mus musculus)	6480464	trimellitic anhydride results in increased expression of GPR183 mRNA	CTD	PMID:19042947
GPR183	Human	troglitazone	decreases expression	ISO	Gpr183 (Rattus norvegicus)	6480464	troglitazone results in decreased expression of GPR183 mRNA	CTD	PMID:21515302
GPR183	Human	tunicamycin	increases expression	EXP		6480464	Tunicamycin results in increased expression of GPR183 mRNA	CTD	PMID:33770205
GPR183	Human	valproic acid	affects expression	ISO	Gpr183 (Mus musculus)	6480464	Valproic Acid affects the expression of GPR183 mRNA	CTD	PMID:17963808
GPR183	Human	valproic acid	decreases expression	EXP		6480464	Valproic Acid results in decreased expression of GPR183 mRNA	CTD	PMID:33770205
GPR183	Human	vorinostat	decreases expression	EXP		6480464	Vorinostat results in decreased expression of GPR183 mRNA	CTD	PMID:33770205
GPR183	Human	XAV939	multiple interactions	EXP		6480464	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPR183 mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPR183 mRNA	CTD	PMID:34480604
GPR183	Human	zinc atom	increases expression	EXP		6480464	Zinc deficiency results in increased expression of GPR183 mRNA	CTD	PMID:18356318
GPR183	Human	zinc(0)	increases expression	EXP		6480464	Zinc deficiency results in increased expression of GPR183 mRNA	CTD	PMID:18356318

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
GPR183	Human	adaptive immune response	involved_in	ISS	UniProtKB:Q3U6B2	150520179		UniProt	GO_REF:0000024
GPR183	Human	adaptive immune response	involved_in	IEA	UniProtKB:Q3U6B2 and ensembl:ENSMUSP00000052404	150520179		Ensembl	GO_REF:0000107
GPR183	Human	adaptive immune response	involved_in	IEA	UniProtKB-KW:KW-1064	150520179		UniProt	GO_REF:0000043
GPR183	Human	B cell activation involved in immune response	involved_in	IBA	MGI:2442034 and PANTHER:PTN008610130	150520179		GO_Central	GO_REF:0000033
GPR183	Human	cell chemotaxis	involved_in	IEA	UniProtKB:Q3U6B2 and ensembl:ENSMUSP00000052404	150520179		Ensembl	GO_REF:0000107
GPR183	Human	dendritic cell chemotaxis	involved_in	ISS	UniProtKB:Q3U6B2	150520179		UniProt	GO_REF:0000024
GPR183	Human	dendritic cell chemotaxis	involved_in	IEA	UniProtKB:Q3U6B2 and ensembl:ENSMUSP00000052404	150520179		Ensembl	GO_REF:0000107
GPR183	Human	dendritic cell homeostasis	involved_in	ISS	UniProtKB:Q3U6B2	150520179		UniProt	GO_REF:0000024
GPR183	Human	dendritic cell homeostasis	involved_in	IEA	UniProtKB:Q3U6B2 and ensembl:ENSMUSP00000052404	150520179		Ensembl	GO_REF:0000107
GPR183	Human	G protein-coupled receptor signaling pathway	involved_in	IEA	InterPro:IPR000276	150520179		InterPro	GO_REF:0000002
GPR183	Human	G protein-coupled receptor signaling pathway	involved_in	IDA		150520179	PMID:18628402 more ...	UniProt	PMID:18628402 more ...
GPR183	Human	G protein-coupled receptor signaling pathway	involved_in	TAS		150520179	PMID:8383238	PINC	PMID:8383238
GPR183	Human	G protein-coupled receptor signaling pathway	involved_in	IEA	UniProtKB-KW:KW-0297	150520179		UniProt	GO_REF:0000043
GPR183	Human	humoral immune response	involved_in	ISS	UniProtKB:Q3U6B2	150520179		UniProt	GO_REF:0000024
GPR183	Human	humoral immune response	involved_in	IEA	UniProtKB:Q3U6B2 and ensembl:ENSMUSP00000052404	150520179		Ensembl	GO_REF:0000107
GPR183	Human	immune response	involved_in	TAS		150520179	PMID:8383238	PINC	PMID:8383238
GPR183	Human	immune system process	involved_in	IEA	UniProtKB-KW:KW-0391	150520179		UniProt	GO_REF:0000043
GPR183	Human	leukocyte chemotaxis	involved_in	IMP		150520179	PMID:24678947	UniProt	PMID:24678947
GPR183	Human	leukocyte chemotaxis	acts_upstream_of_or_within	IEA	UniProtKB:Q3U6B2 and ensembl:ENSMUSP00000052404	150520179		Ensembl	GO_REF:0000107
GPR183	Human	mature B cell differentiation involved in immune response	involved_in	ISS	UniProtKB:Q3U6B2	150520179		UniProt	GO_REF:0000024
GPR183	Human	mature B cell differentiation involved in immune response	involved_in	IEA	UniProtKB:Q3U6B2 and ensembl:ENSMUSP00000052404	150520179		Ensembl	GO_REF:0000107
GPR183	Human	osteoclast differentiation	involved_in	IEA	UniProtKB:Q3U6B2 and ensembl:ENSMUSP00000052404	150520179		Ensembl	GO_REF:0000107
GPR183	Human	osteoclast differentiation	involved_in	ISS	UniProtKB:Q3U6B2	150520179		UniProt	GO_REF:0000024
GPR183	Human	positive regulation of B cell proliferation	involved_in	IDA		150520179	PMID:21673108	UniProt	PMID:21673108
GPR183	Human	positive regulation of B cell proliferation	involved_in	IEA	UniProtKB:Q3U6B2 and ensembl:ENSMUSP00000052404	150520179		Ensembl	GO_REF:0000107
GPR183	Human	positive regulation of ERK1 and ERK2 cascade	involved_in	IDA		150520179	PMID:21673108 and PMID:25297897	UniProt	PMID:21673108 and PMID:25297897
GPR183	Human	regulation of astrocyte chemotaxis	involved_in	IDA		150520179	PMID:25297897	UniProt	PMID:25297897
GPR183	Human	signal transduction	involved_in	IEA	UniProtKB-KW:KW-0807	150520179		UniProt	GO_REF:0000043
GPR183	Human	T cell chemotaxis	involved_in	ISS	UniProtKB:Q3U6B2	150520179		UniProt	GO_REF:0000024
GPR183	Human	T cell chemotaxis	involved_in	IEA	UniProtKB:Q3U6B2 and ensembl:ENSMUSP00000052404	150520179		Ensembl	GO_REF:0000107
GPR183	Human	T follicular helper cell differentiation	involved_in	IEA	UniProtKB:Q3U6B2 and ensembl:ENSMUSP00000052404	150520179		Ensembl	GO_REF:0000107
GPR183	Human	T follicular helper cell differentiation	involved_in	ISS	UniProtKB:Q3U6B2	150520179		UniProt	GO_REF:0000024

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
GPR183	Human	membrane	located_in	IEA	InterPro:IPR000276 and InterPro:IPR017452	150520179		InterPro	GO_REF:0000002
GPR183	Human	membrane	located_in	IEA	UniProtKB-KW:KW-0472	150520179		UniProt	GO_REF:0000043
GPR183	Human	nucleoplasm	located_in	IDA		150520179		HPA	GO_REF:0000052
GPR183	Human	plasma membrane	located_in	IEA	UniProtKB-KW:KW-1003	150520179		UniProt	GO_REF:0000043
GPR183	Human	plasma membrane	located_in	IDA		150520179	PMID:18628402 more ...	HPA	GO_REF:0000052 more ...
GPR183	Human	plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0039	150520179		UniProt	GO_REF:0000044
GPR183	Human	plasma membrane	located_in	TAS		150520179	PMID:8383238	Reactome	PMID:8383238 more ...

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
GPR183	Human	G protein-coupled receptor activity	enables	IDA		150520179	PMID:18628402 more ...	UniProt	PMID:18628402 more ...
GPR183	Human	G protein-coupled receptor activity	enables	IBA	PANTHER:PTN001201699 more ...	150520179		GO_Central	GO_REF:0000033
GPR183	Human	G protein-coupled receptor activity	enables	IEA	InterPro:IPR000276 and InterPro:IPR047160	150520179		InterPro	GO_REF:0000002
GPR183	Human	G protein-coupled receptor activity	enables	IEA	UniProtKB-KW:KW-0297	150520179		UniProt	GO_REF:0000043
GPR183	Human	G protein-coupled receptor activity	enables	TAS		150520179	PMID:8383238	PINC	PMID:8383238
GPR183	Human	oxysterol binding	enables	IMP		150520179	PMID:24678947	UniProt	PMID:24678947
GPR183	Human	oxysterol binding	enables	IEA	InterPro:IPR047160	150520179		InterPro	GO_REF:0000002
GPR183	Human	oxysterol binding	enables	IEA	UniProtKB:Q3U6B2 and ensembl:ENSMUSP00000052404	150520179		Ensembl	GO_REF:0000107
GPR183	Human	oxysterol binding	enables	IDA		150520179	PMID:21796212 more ...	UniProt	PMID:21796212 more ...

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
GPR183	Human	Lobar holoprosencephaly		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Lobar holoprosencephaly	ClinVar

#	Reference Title	Reference Citation
1.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
2.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

PMID:8125298	PMID:8383238	PMID:12477932	PMID:15489334	PMID:16169070	PMID:16540462	PMID:18628402	PMID:21261596	PMID:21673108	PMID:21796212	PMID:21873635	PMID:22875855
PMID:22913878	PMID:22930711	PMID:23128233	PMID:23333304	PMID:23473835	PMID:24480442	PMID:24678947	PMID:25297897	PMID:26186194	PMID:26898310	PMID:27902324	PMID:28003273
PMID:28052250	PMID:28125291	PMID:28514442	PMID:30742043	PMID:31550518	PMID:33240287	PMID:33511653	PMID:33961781	PMID:34229205	PMID:35351968	PMID:35875859	PMID:37469011
PMID:38770825	PMID:38877985

GPR183
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	13	99,294,539 - 99,307,399 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	13	99,294,539 - 99,307,399 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	13	99,946,793 - 99,959,653 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	13	98,744,790 - 98,757,695 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	13	98,744,790 - 98,757,695	NCBI
Celera	13	80,790,353 - 80,803,314 (-)	NCBI		Celera
Cytogenetic Map	13	q32.3	NCBI
HuRef	13	80,541,169 - 80,554,130 (-)	NCBI		HuRef
CHM1_1	13	99,916,965 - 99,929,926 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	13	98,504,775 - 98,517,640 (-)	NCBI		T2T-CHM13v2.0

Gpr183
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	14	122,189,743 - 122,202,605 (-)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	14	122,189,963 - 122,202,607 (-)	Ensembl		GRCm39 Ensembl
GRCm38	14	121,952,331 - 121,965,193 (-)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	14	121,952,551 - 121,965,195 (-)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	14	122,351,553 - 122,364,415 (-)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	14	121,087,511 - 121,100,373 (-)	NCBI		MGSCv36	mm8
Celera	14	120,513,847 - 120,526,678 (-)	NCBI		Celera
Cytogenetic Map	14	E5	NCBI
cM Map	14	65.86	NCBI

Gpr183
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	15	105,445,129 - 105,457,192 (-)	NCBI		GRCr8
mRatBN7.2	15	99,037,764 - 99,050,550 (-)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	15	99,036,367 - 99,050,559 (-)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	15	102,972,724 - 102,984,243 (-)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	15	104,064,748 - 104,076,273 (-)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	15	100,992,568 - 101,004,093 (-)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	15	108,364,701 - 108,376,221 (-)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	15	108,364,701 - 108,376,221 (-)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	15	111,751,148 - 111,763,869 (-)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	15	107,056,367 - 107,067,887 (-)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
Celera	15	97,811,478 - 97,823,000 (-)	NCBI		Celera
Cytogenetic Map	15	q25	NCBI

Gpr183
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955404	11,264,954 - 11,277,531 (+)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955404	11,264,954 - 11,277,531 (+)	NCBI	ChiLan1.0	ChiLan1.0

GPR183
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	14	100,818,658 - 100,837,495 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	13	99,485,636 - 99,498,792 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	13	80,461,908 - 80,475,046 (-)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	13	99,600,695 - 99,613,671 (-)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	13	99,601,220 - 99,602,305 (-)	Ensembl	panpan1.1		panPan2

GPR183
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	22	49,332,665 - 49,347,721 (-)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	22	49,333,188 - 49,347,593 (-)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	22	49,113,865 - 49,128,934 (-)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	22	49,773,993 - 49,789,040 (-)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	22	49,774,006 - 49,789,026 (-)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	22	49,425,293 - 49,440,355 (-)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	22	49,459,634 - 49,474,711 (-)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	22	49,495,775 - 49,510,831 (-)	NCBI		UU_Cfam_GSD_1.0

Gpr183
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024404945	184,753,026 - 184,765,923 (-)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936472	11,186,267 - 11,198,832 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936472	11,196,567 - 11,198,890 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

GPR183
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	11	68,231,224 - 68,245,751 (-)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	11	68,231,851 - 68,248,627 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	11	75,527,987 - 75,529,869 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

GPR183
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	3	77,952,689 - 77,966,317 (-)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	3	77,953,212 - 77,954,297 (-)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666046	34,448,232 - 34,461,198 (-)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Variants in GPR183
24 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 13q31.1-34(chr13:82581008-114327173)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051380]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051380]\|See cases [RCV000051380]	Chr13:82581008..114327173 [GRCh38] Chr13:83155143..115085141 [GRCh37] Chr13:82053144..114110750 [NCBI36] Chr13:13q31.1-34	pathogenic
GRCh38/hg38 13q31.3-34(chr13:91366227-114327314)x1	copy number loss	See cases [RCV000051418]	Chr13:91366227..114327314 [GRCh38] Chr13:92018481..115085141 [GRCh37] Chr13:90816482..114110891 [NCBI36] Chr13:13q31.3-34	pathogenic
GRCh38/hg38 13q32.3-33.1(chr13:99034367-101217397)x1	copy number loss	See cases [RCV000051420]	Chr13:99034367..101217397 [GRCh38] Chr13:99686621..101869748 [GRCh37] Chr13:98484622..100667749 [NCBI36] Chr13:13q32.3-33.1	pathogenic
GRCh38/hg38 13q31.1-33.2(chr13:82032938-106082542)x3	copy number gain	See cases [RCV000051179]	Chr13:82032938..106082542 [GRCh38] Chr13:82607073..106734891 [GRCh37] Chr13:81505074..105532892 [NCBI36] Chr13:13q31.1-33.2	pathogenic
GRCh38/hg38 13q32.2-32.3(chr13:97674476-99498445)x3	copy number gain	See cases [RCV000052030]	Chr13:97674476..99498445 [GRCh38] Chr13:98326730..100150699 [GRCh37] Chr13:97124731..98948700 [NCBI36] Chr13:13q32.2-32.3	uncertain significance
GRCh38/hg38 13q12.11-34(chr13:19837395-114327173)x3	copy number gain	See cases [RCV000053731]	Chr13:19837395..114327173 [GRCh38] Chr13:20411535..115085141 [GRCh37] Chr13:19309535..114110750 [NCBI36] Chr13:13q12.11-34	pathogenic
GRCh38/hg38 13q11-34(chr13:18565048-114327173)x3	copy number gain	See cases [RCV000053719]	Chr13:18565048..114327173 [GRCh38] Chr13:19139188..115085141 [GRCh37] Chr13:18037188..114110750 [NCBI36] Chr13:13q11-34	pathogenic
GRCh38/hg38 13q11-34(chr13:18850545-114327173)x3	copy number gain	See cases [RCV000053723]	Chr13:18850545..114327173 [GRCh38] Chr13:19296527..115085141 [GRCh37] Chr13:18194527..114110750 [NCBI36] Chr13:13q11-34	pathogenic
GRCh38/hg38 13q12.11-34(chr13:18946182-114304628)x3	copy number gain	See cases [RCV000053726]	Chr13:18946182..114304628 [GRCh38] Chr13:19520322..115070103 [GRCh37] Chr13:18418322..114088205 [NCBI36] Chr13:13q12.11-34	pathogenic
GRCh38/hg38 13q13.2-34(chr13:33528097-114327173)x3	copy number gain	See cases [RCV000053759]	Chr13:33528097..114327173 [GRCh38] Chr13:34102234..115085141 [GRCh37] Chr13:33000234..114110750 [NCBI36] Chr13:13q13.2-34	pathogenic
GRCh38/hg38 13q31.3-33.1(chr13:93213623-101537104)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053790]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053790]\|See cases [RCV000053790]	Chr13:93213623..101537104 [GRCh38] Chr13:93865876..102189455 [GRCh37] Chr13:92663877..100987456 [NCBI36] Chr13:13q31.3-33.1	pathogenic
GRCh38/hg38 13q14.11-34(chr13:43219125-114327314)x3	copy number gain	See cases [RCV000053762]	Chr13:43219125..114327314 [GRCh38] Chr13:43793261..115085141 [GRCh37] Chr13:42691261..114110891 [NCBI36] Chr13:13q14.11-34	pathogenic
GRCh38/hg38 13q14.11-34(chr13:44164751-114327173)x3	copy number gain	See cases [RCV000053764]	Chr13:44164751..114327173 [GRCh38] Chr13:44738887..115085141 [GRCh37] Chr13:43636887..114110750 [NCBI36] Chr13:13q14.11-34	pathogenic
GRCh38/hg38 13q14.12-34(chr13:44733046-114327173)x3	copy number gain	See cases [RCV000053767]	Chr13:44733046..114327173 [GRCh38] Chr13:45307182..115085141 [GRCh37] Chr13:44205182..114110750 [NCBI36] Chr13:13q14.12-34	pathogenic
GRCh38/hg38 13q22.1-34(chr13:74345951-114327314)x3	copy number gain	See cases [RCV000053770]	Chr13:74345951..114327314 [GRCh38] Chr13:74920088..115085141 [GRCh37] Chr13:73818089..114110891 [NCBI36] Chr13:13q22.1-34	pathogenic
GRCh38/hg38 13q31.1-34(chr13:80628584-114327173)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053772]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053772]\|See cases [RCV000053772]	Chr13:80628584..114327173 [GRCh38] Chr13:81202719..115085141 [GRCh37] Chr13:80100720..114110750 [NCBI36] Chr13:13q31.1-34	pathogenic
GRCh37/hg19 13q32.1-33.2(chr13:95700999-105271065)x3	copy number gain	See cases [RCV003159553]	Chr13:95700999..105271065 [GRCh37] Chr13:13q32.1-33.2	pathogenic
GRCh38/hg38 13q32.2-33.1(chr13:98008015-103697232)x3	copy number gain	See cases [RCV000133986]	Chr13:98008015..103697232 [GRCh38] Chr13:98660269..104349582 [GRCh37] Chr13:97458270..103147583 [NCBI36] Chr13:13q32.2-33.1	pathogenic
GRCh38/hg38 13q12.11-34(chr13:19833130-114298614)x3	copy number gain	See cases [RCV000134104]	Chr13:19833130..114298614 [GRCh38] Chr13:20407270..115064089 [GRCh37] Chr13:19305270..114082191 [NCBI36] Chr13:13q12.11-34	pathogenic
GRCh38/hg38 13q11-34(chr13:18445862-114327173)x1	copy number loss	See cases [RCV000135610]	Chr13:18445862..114327173 [GRCh38] Chr13:19020001..115085141 [GRCh37] Chr13:10098739..114110750 [NCBI36] Chr13:13q11-34	pathogenic
GRCh38/hg38 13q31.2-34(chr13:88937651-114327173)x3	copy number gain	See cases [RCV000137102]	Chr13:88937651..114327173 [GRCh38] Chr13:89589905..115085141 [GRCh37] Chr13:88387906..114110750 [NCBI36] Chr13:13q31.2-34	pathogenic
GRCh38/hg38 13q31.3-33.3(chr13:93345058-109458154)x1	copy number loss	See cases [RCV000136688]	Chr13:93345058..109458154 [GRCh38] Chr13:93997311..110110501 [GRCh37] Chr13:92795312..108908502 [NCBI36] Chr13:13q31.3-33.3	pathogenic
GRCh38/hg38 13q32.1-33.3(chr13:97213871-109162916)x1	copy number loss	See cases [RCV000138024]	Chr13:97213871..109162916 [GRCh38] Chr13:97866125..109815264 [GRCh37] Chr13:96664126..108613265 [NCBI36] Chr13:13q32.1-33.3	pathogenic
GRCh38/hg38 13q14.11-34(chr13:40942298-114340331)x1	copy number loss	See cases [RCV000137893]	Chr13:40942298..114340331 [GRCh38] Chr13:41516434..115085141 [GRCh37] Chr13:40414434..114123908 [NCBI36] Chr13:13q14.11-34	pathogenic
GRCh38/hg38 13q31.1-34(chr13:78999318-114327106)x3	copy number gain	See cases [RCV000138742]	Chr13:78999318..114327106 [GRCh38] Chr13:79573453..115085141 [GRCh37] Chr13:78471454..114110683 [NCBI36] Chr13:13q31.1-34	pathogenic
GRCh38/hg38 13q31.1-34(chr13:86788927-114340331)x1	copy number loss	See cases [RCV000138340]	Chr13:86788927..114340331 [GRCh38] Chr13:87441182..115085141 [GRCh37] Chr13:86239183..114123908 [NCBI36] Chr13:13q31.1-34	pathogenic
GRCh38/hg38 13q12.11-34(chr13:19833130-114327106)x3	copy number gain	See cases [RCV000139078]	Chr13:19833130..114327106 [GRCh38] Chr13:20407270..115085141 [GRCh37] Chr13:19305270..114110683 [NCBI36] Chr13:13q12.11-34	pathogenic
GRCh38/hg38 13q32.1-34(chr13:95744855-110863818)x3	copy number gain	See cases [RCV000139021]	Chr13:95744855..110863818 [GRCh38] Chr13:96397109..111516165 [GRCh37] Chr13:95195110..110314166 [NCBI36] Chr13:13q32.1-34	pathogenic
GRCh38/hg38 13q31.2-32.3(chr13:87944479-99866542)x1	copy number loss	See cases [RCV000139047]	Chr13:87944479..99866542 [GRCh38] Chr13:88596734..100518796 [GRCh37] Chr13:87394735..99316797 [NCBI36] Chr13:13q31.2-32.3	pathogenic
GRCh38/hg38 13q32.1-34(chr13:96745059-114327106)x3	copy number gain	See cases [RCV000139160]	Chr13:96745059..114327106 [GRCh38] Chr13:97397313..115085141 [GRCh37] Chr13:96195314..114110683 [NCBI36] Chr13:13q32.1-34	pathogenic
GRCh38/hg38 13q11-34(chr13:18456040-114340285)x3	copy number gain	See cases [RCV000140004]	Chr13:18456040..114340285 [GRCh38] Chr13:19030180..115105760 [GRCh37] Chr13:17928180..114123862 [NCBI36] Chr13:13q11-34	pathogenic
GRCh38/hg38 13q31.1-34(chr13:78964223-114340331)x3	copy number gain	See cases [RCV000141248]	Chr13:78964223..114340331 [GRCh38] Chr13:79538358..115085141 [GRCh37] Chr13:78436359..114123908 [NCBI36] Chr13:13q31.1-34	pathogenic
GRCh38/hg38 13q31.1-34(chr13:83288131-114342258)x3	copy number gain	See cases [RCV000141804]	Chr13:83288131..114342258 [GRCh38] Chr13:83862266..115107733 [GRCh37] Chr13:82760267..114125835 [NCBI36] Chr13:13q31.1-34	pathogenic
GRCh38/hg38 13q12.11-34(chr13:19671934-114340331)x3	copy number gain	See cases [RCV000142924]	Chr13:19671934..114340331 [GRCh38] Chr13:20246074..115085141 [GRCh37] Chr13:19144074..114123908 [NCBI36] Chr13:13q12.11-34	pathogenic
GRCh38/hg38 13q11-34(chr13:18862146-114342258)x3	copy number gain	See cases [RCV000143462]	Chr13:18862146..114342258 [GRCh38] Chr13:19436286..115107733 [GRCh37] Chr13:18334286..114125835 [NCBI36] Chr13:13q11-34	pathogenic
GRCh38/hg38 13q12.11-34(chr13:19837395-114327173)x3	copy number gain	See cases [RCV000148126]	Chr13:19837395..114327173 [GRCh38] Chr13:20411535..115085141 [GRCh37] Chr13:19309535..114110750 [NCBI36] Chr13:13q12.11-34	pathogenic
GRCh37/hg19 13q12.11-34(chr13:19571503-115092569)x3	copy number gain	See cases [RCV000240150]	Chr13:19571503..115092569 [GRCh37] Chr13:13q12.11-34	pathogenic
GRCh37/hg19 13q31.2-34(chr13:89796110-115083342)x1	copy number loss	See cases [RCV000240161]	Chr13:89796110..115083342 [GRCh37] Chr13:13q31.2-34	pathogenic
GRCh37/hg19 13q14.3-33.3(chr13:53551300-109850651)x1	copy number loss	See cases [RCV000449272]	Chr13:53551300..109850651 [GRCh37] Chr13:13q14.3-33.3	pathogenic
GRCh37/hg19 13q21.2-34(chr13:61424168-115107733)x3	copy number gain	See cases [RCV000449118]	Chr13:61424168..115107733 [GRCh37] Chr13:13q21.2-34	pathogenic
GRCh37/hg19 13q12.11-34(chr13:19571503-115092510)	copy number gain	See cases [RCV000449142]	Chr13:19571503..115092510 [GRCh37] Chr13:13q12.11-34	pathogenic
GRCh37/hg19 13q32.1-32.3(chr13:95677119-100521192)x1	copy number loss	See cases [RCV000447261]	Chr13:95677119..100521192 [GRCh37] Chr13:13q32.1-32.3	uncertain significance
GRCh37/hg19 13q31.3-34(chr13:94269729-115107733)x3	copy number gain	See cases [RCV000447545]	Chr13:94269729..115107733 [GRCh37] Chr13:13q31.3-34	pathogenic
GRCh37/hg19 13q31.1-34(chr13:82221361-115092569)x3	copy number gain	See cases [RCV000447429]	Chr13:82221361..115092569 [GRCh37] Chr13:13q31.1-34	pathogenic
GRCh37/hg19 13q11-34(chr13:19436286-115107733)x3	copy number gain	See cases [RCV000445886]	Chr13:19436286..115107733 [GRCh37] Chr13:13q11-34	pathogenic
GRCh37/hg19 13q21.1-34(chr13:56431743-115107733)	copy number gain	See cases [RCV000510722]	Chr13:56431743..115107733 [GRCh37] Chr13:13q21.1-34	pathogenic
GRCh37/hg19 13q31.1-33.1(chr13:81851091-102864674)x1	copy number loss	See cases [RCV000448988]	Chr13:81851091..102864674 [GRCh37] Chr13:13q31.1-33.1	pathogenic
GRCh37/hg19 13q32.3(chr13:99910600-100909782)	copy number gain	See cases [RCV000448013]	Chr13:99910600..100909782 [GRCh37] Chr13:13q32.3	uncertain significance
GRCh37/hg19 13q31.2-34(chr13:88073140-115107733)x1	copy number loss	See cases [RCV000448405]	Chr13:88073140..115107733 [GRCh37] Chr13:13q31.2-34	pathogenic
GRCh37/hg19 13q32.1-33.1(chr13:98158452-101950563)x3	copy number gain	See cases [RCV000510477]	Chr13:98158452..101950563 [GRCh37] Chr13:13q32.1-33.1	likely pathogenic
GRCh37/hg19 13q11-34(chr13:19436287-115107733)	copy number gain	See cases [RCV000510405]	Chr13:19436287..115107733 [GRCh37] Chr13:13q11-34	pathogenic
GRCh37/hg19 13q31.3-34(chr13:94474530-115107733)x1	copy number loss	See cases [RCV000510535]	Chr13:94474530..115107733 [GRCh37] Chr13:13q31.3-34	pathogenic
GRCh37/hg19 13q21.33-34(chr13:71871468-115107733)x4	copy number gain	See cases [RCV000510281]	Chr13:71871468..115107733 [GRCh37] Chr13:13q21.33-34	pathogenic
GRCh37/hg19 13q31.1-34(chr13:80058840-115107733)x3	copy number gain	See cases [RCV000510566]	Chr13:80058840..115107733 [GRCh37] Chr13:13q31.1-34	pathogenic
GRCh37/hg19 13q32.2-33.1(chr13:98607855-104370539)x3	copy number gain	See cases [RCV000510620]	Chr13:98607855..104370539 [GRCh37] Chr13:13q32.2-33.1	likely pathogenic
GRCh37/hg19 13q11-34(chr13:19436287-115107733)x3	copy number gain	See cases [RCV000511880]	Chr13:19436287..115107733 [GRCh37] Chr13:13q11-34	pathogenic
GRCh37/hg19 13q31.1-33.3(chr13:80572498-108719528)x1	copy number loss	See cases [RCV000510890]	Chr13:80572498..108719528 [GRCh37] Chr13:13q31.1-33.3	pathogenic
GRCh37/hg19 13q32.3(chr13:99333632-100773336)x1	copy number loss	See cases [RCV000511270]	Chr13:99333632..100773336 [GRCh37] Chr13:13q32.3	pathogenic
GRCh37/hg19 13q32.1-34(chr13:96586481-115107733)x1	copy number loss	See cases [RCV000512257]	Chr13:96586481..115107733 [GRCh37] Chr13:13q32.1-34	pathogenic
GRCh37/hg19 13q31.1-34(chr13:83435292-115107733)x3	copy number gain	See cases [RCV000512605]	Chr13:83435292..115107733 [GRCh37] Chr13:13q31.1-34	pathogenic
GRCh37/hg19 13q31.1-34(chr13:85176519-115107733)x3	copy number gain	See cases [RCV000512242]	Chr13:85176519..115107733 [GRCh37] Chr13:13q31.1-34	pathogenic
GRCh37/hg19 13q22.3-34(chr13:78590089-115107733)x3	copy number gain	not provided [RCV000683571]	Chr13:78590089..115107733 [GRCh37] Chr13:13q22.3-34	pathogenic
GRCh37/hg19 13q31.3-33.3(chr13:94703767-109731879)x1	copy number loss	not provided [RCV000683570]	Chr13:94703767..109731879 [GRCh37] Chr13:13q31.3-33.3	pathogenic
GRCh37/hg19 13q11-34(chr13:19058717-115103529)x3	copy number gain	not provided [RCV000738115]	Chr13:19058717..115103529 [GRCh37] Chr13:13q11-34	pathogenic
GRCh37/hg19 13q11-34(chr13:19031237-115107157)x3	copy number gain	not provided [RCV000750643]	Chr13:19031237..115107157 [GRCh37] Chr13:13q11-34	pathogenic
GRCh37/hg19 13q31.3-34(chr13:94849303-115107733)x3	copy number gain	not provided [RCV000847710]	Chr13:94849303..115107733 [GRCh37] Chr13:13q31.3-34	uncertain significance
GRCh37/hg19 13q14.3-34(chr13:53262013-115107733)x1	copy number loss	not provided [RCV001006567]	Chr13:53262013..115107733 [GRCh37] Chr13:13q14.3-34	pathogenic
GRCh37/hg19 13q21.2-34(chr13:61775567-115107733)x3	copy number gain	not provided [RCV000848025]	Chr13:61775567..115107733 [GRCh37] Chr13:13q21.2-34	pathogenic
GRCh37/hg19 13q11-34(chr13:19436286-115107733)x3	copy number gain	not provided [RCV000849129]	Chr13:19436286..115107733 [GRCh37] Chr13:13q11-34	pathogenic
GRCh37/hg19 13q22.1-34(chr13:75268539-115107733)x3	copy number gain	not provided [RCV002472537]	Chr13:75268539..115107733 [GRCh37] Chr13:13q22.1-34	pathogenic
GRCh37/hg19 13q31.3-33.2(chr13:93535335-105788229)x1	copy number loss	not provided [RCV002473593]	Chr13:93535335..105788229 [GRCh37] Chr13:13q31.3-33.2	pathogenic
GRCh37/hg19 13q32.1-33.2(chr13:96240346-106103782)x1	copy number loss	not provided [RCV001006589]	Chr13:96240346..106103782 [GRCh37] Chr13:13q32.1-33.2	pathogenic
GRCh37/hg19 13q32.1-34(chr13:96895656-115107733)x1	copy number loss	not provided [RCV001006591]	Chr13:96895656..115107733 [GRCh37] Chr13:13q32.1-34	pathogenic
GRCh37/hg19 13p13-q34(chr13:1-115169878)	copy number gain	Complete trisomy 13 syndrome [RCV002280659]	Chr13:1..115169878 [GRCh37] Chr13:13p13-q34	pathogenic
NC_000013.10:g.(?_92002837)_(103343314_?)del	deletion	Holoprosencephaly 5 [RCV001388033]	Chr13:92002837..103343314 [GRCh37] Chr13:13q31.3-33.1	pathogenic
GRCh37/hg19 13q11-34(chr13:19053605-115108528)x3	copy number gain	See cases [RCV001353184]	Chr13:19053605..115108528 [GRCh37] Chr13:13q11-34	pathogenic
Single allele	deletion	Distal monosomy 13q [RCV001391677]	Chr13:94679977..111536145 [GRCh37] Chr13:13q31.3-34	pathogenic
GRCh37/hg19 13p13-q34(chr13:1-115169878)x3	copy number gain	See cases [RCV001780076]	Chr13:1..115169878 [GRCh37] Chr13:13p13-q34	pathogenic
GRCh37/hg19 13q14.11-33.3(chr13:42504540-108206269)x3	copy number gain	not provided [RCV001829235]	Chr13:42504540..108206269 [GRCh37] Chr13:13q14.11-33.3	pathogenic
GRCh37/hg19 13q22.3-34(chr13:78514567-115107733)	copy number gain	not specified [RCV002053071]	Chr13:78514567..115107733 [GRCh37] Chr13:13q22.3-34	pathogenic
GRCh37/hg19 13q11-34(chr13:19436286-115107733)x3	copy number gain	not provided [RCV001834436]	Chr13:19436286..115107733 [GRCh37] Chr13:13q11-34	pathogenic
GRCh37/hg19 13q21.2-34(chr13:61424168-115107733)	copy number gain	not specified [RCV002053063]	Chr13:61424168..115107733 [GRCh37] Chr13:13q21.2-34	pathogenic
GRCh37/hg19 13q31.2-34(chr13:88073140-115107733)	copy number loss	not specified [RCV002053074]	Chr13:88073140..115107733 [GRCh37] Chr13:13q31.2-34	pathogenic
GRCh37/hg19 13q31.1-34(chr13:85037147-115107733)	copy number gain	not specified [RCV002053073]	Chr13:85037147..115107733 [GRCh37] Chr13:13q31.1-34	pathogenic
GRCh37/hg19 13q11-34(chr13:19436286-114981726)	copy number gain	not specified [RCV002053035]	Chr13:19436286..114981726 [GRCh37] Chr13:13q11-34	pathogenic
GRCh37/hg19 13q11-34(chr13:19436286-115107733)	copy number gain	not specified [RCV002053036]	Chr13:19436286..115107733 [GRCh37] Chr13:13q11-34	pathogenic
GRCh37/hg19 13q31.1-34(chr13:79370012-115107733)	copy number loss	not specified [RCV002053072]	Chr13:79370012..115107733 [GRCh37] Chr13:13q31.1-34	pathogenic
NC_000013.10:g.99162946_101376965del	deletion	Lobar holoprosencephaly [RCV001847319]	Chr13:99162946..101376965 [GRCh37] Chr13:13q32.2-32.3	pathogenic
GRCh37/hg19 13q32.1-32.3(chr13:95677119-100521192)	copy number loss	not specified [RCV002053076]	Chr13:95677119..100521192 [GRCh37] Chr13:13q32.1-32.3	uncertain significance
NC_000013.10:g.(?_99336978)_(102379160_?)del	deletion	Holoprosencephaly 5 [RCV003109612]	Chr13:99336978..102379160 [GRCh37] Chr13:13q32.3-33.1	pathogenic
GRCh37/hg19 13q11-34(chr13:19253848-115108937)x3	copy number gain	not provided [RCV002291540]	Chr13:19253848..115108937 [GRCh37] Chr13:13q11-34	pathogenic
GRCh37/hg19 13q31.2-34(chr13:89490345-115062235)x3	copy number gain	See cases [RCV002286354]	Chr13:89490345..115062235 [GRCh37] Chr13:13q31.2-34	pathogenic
GRCh37/hg19 13q32.1-34(chr13:97142120-115107733)x1	copy number loss	not provided [RCV002474828]	Chr13:97142120..115107733 [GRCh37] Chr13:13q32.1-34	pathogenic
NM_004951.5(GPR183):c.751G>A (p.Val251Ile)	single nucleotide variant	not specified [RCV004204225]	Chr13:99295395 [GRCh38] Chr13:99947649 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.16G>A (p.Ala6Thr)	single nucleotide variant	not specified [RCV004237536]	Chr13:99296130 [GRCh38] Chr13:99948384 [GRCh37] Chr13:13q32.3	uncertain significance
GRCh37/hg19 13q32.3-34(chr13:99421603-115107733)x3	copy number gain	not provided [RCV002475671]	Chr13:99421603..115107733 [GRCh37] Chr13:13q32.3-34	pathogenic
NM_004951.5(GPR183):c.1073C>T (p.Ser358Leu)	single nucleotide variant	not specified [RCV004157115]	Chr13:99295073 [GRCh38] Chr13:99947327 [GRCh37] Chr13:13q32.3	likely benign
NM_004951.5(GPR183):c.101T>C (p.Met34Thr)	single nucleotide variant	not specified [RCV004173323]	Chr13:99296045 [GRCh38] Chr13:99948299 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.86C>T (p.Thr29Met)	single nucleotide variant	not specified [RCV004188515]	Chr13:99296060 [GRCh38] Chr13:99948314 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.121G>A (p.Val41Ile)	single nucleotide variant	not specified [RCV004271138]	Chr13:99296025 [GRCh38] Chr13:99948279 [GRCh37] Chr13:13q32.3	uncertain significance
GRCh38/hg38 13q32.2-34(chr13:98343655-110990677)x1	copy number loss	Holoprosencephaly 5 [RCV003327700]	Chr13:98343655..110990677 [GRCh38] Chr13:13q32.2-34	pathogenic
NM_004951.5(GPR183):c.929T>C (p.Phe310Ser)	single nucleotide variant	not specified [RCV004357375]	Chr13:99295217 [GRCh38] Chr13:99947471 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.413G>A (p.Arg138His)	single nucleotide variant	not specified [RCV004342803]	Chr13:99295733 [GRCh38] Chr13:99947987 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.52G>A (p.Gly18Arg)	single nucleotide variant	not specified [RCV004365016]	Chr13:99296094 [GRCh38] Chr13:99948348 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.1031G>A (p.Arg344His)	single nucleotide variant	not specified [RCV004354337]	Chr13:99295115 [GRCh38] Chr13:99947369 [GRCh37] Chr13:13q32.3	uncertain significance
GRCh37/hg19 13q31.1-34(chr13:82131211-115107733)x1	copy number loss	not provided [RCV003483192]	Chr13:82131211..115107733 [GRCh37] Chr13:13q31.1-34	pathogenic
GRCh37/hg19 13q22.1-34(chr13:73488238-115107733)x3	copy number gain	not provided [RCV003484901]	Chr13:73488238..115107733 [GRCh37] Chr13:13q22.1-34	pathogenic
GRCh37/hg19 13q21.33-33.1(chr13:73132193-104595598)x1	copy number loss	not provided [RCV003483190]	Chr13:73132193..104595598 [GRCh37] Chr13:13q21.33-33.1	pathogenic
GRCh37/hg19 13q31.2-33.2(chr13:89012420-106371634)x1	copy number loss	not provided [RCV003483195]	Chr13:89012420..106371634 [GRCh37] Chr13:13q31.2-33.2	pathogenic
GRCh37/hg19 13q21.2-34(chr13:61534068-115107733)x3	copy number gain	not provided [RCV003484899]	Chr13:61534068..115107733 [GRCh37] Chr13:13q21.2-34	pathogenic
GRCh37/hg19 13q31.1-34(chr13:84669397-115107733)x1	copy number loss	not specified [RCV003987038]	Chr13:84669397..115107733 [GRCh37] Chr13:13q31.1-34	pathogenic
GRCh37/hg19 13q31.1-34(chr13:82876219-115107733)x3	copy number gain	not specified [RCV003987023]	Chr13:82876219..115107733 [GRCh37] Chr13:13q31.1-34	pathogenic
GRCh37/hg19 13q21.31-33.1(chr13:64825656-103641349)x1	copy number loss	not specified [RCV003987009]	Chr13:64825656..103641349 [GRCh37] Chr13:13q21.31-33.1	pathogenic
GRCh37/hg19 13q32.2-33.3(chr13:98773859-109277603)x1	copy number loss	not provided [RCV004442778]	Chr13:98773859..109277603 [GRCh37] Chr13:13q32.2-33.3	pathogenic
NM_004951.5(GPR183):c.295A>T (p.Ile99Phe)	single nucleotide variant	not specified [RCV004390989]	Chr13:99295851 [GRCh38] Chr13:99948105 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.202C>T (p.Leu68Phe)	single nucleotide variant	not specified [RCV004390986]	Chr13:99295944 [GRCh38] Chr13:99948198 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.801T>A (p.His267Gln)	single nucleotide variant	not specified [RCV004390991]	Chr13:99295345 [GRCh38] Chr13:99947599 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.1045A>G (p.Thr349Ala)	single nucleotide variant	not specified [RCV004390984]	Chr13:99295101 [GRCh38] Chr13:99947355 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.269A>T (p.Tyr90Phe)	single nucleotide variant	not specified [RCV004390987]	Chr13:99295877 [GRCh38] Chr13:99948131 [GRCh37] Chr13:13q32.3	uncertain significance
GRCh37/hg19 13q32.3-34(chr13:99892724-115108414)x3	copy number gain	not provided [RCV004577499]	Chr13:99892724..115108414 [GRCh37] Chr13:13q32.3-34	pathogenic
NM_004951.5(GPR183):c.139G>A (p.Val47Met)	single nucleotide variant	not specified [RCV004390985]	Chr13:99296007 [GRCh38] Chr13:99948261 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.566A>T (p.Glu189Val)	single nucleotide variant	not specified [RCV004390990]	Chr13:99295580 [GRCh38] Chr13:99947834 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.490C>T (p.Leu164Phe)	single nucleotide variant	not specified [RCV004632460]	Chr13:99295656 [GRCh38] Chr13:99947910 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.98T>C (p.Val33Ala)	single nucleotide variant	not specified [RCV004922390]	Chr13:99296048 [GRCh38] Chr13:99948302 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.944A>G (p.Tyr315Cys)	single nucleotide variant	not specified [RCV004922391]	Chr13:99295202 [GRCh38] Chr13:99947456 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.973C>T (p.Arg325Trp)	single nucleotide variant	not specified [RCV004922388]	Chr13:99295173 [GRCh38] Chr13:99947427 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.323C>T (p.Ala108Val)	single nucleotide variant	not specified [RCV004922387]	Chr13:99295823 [GRCh38] Chr13:99948077 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.1058T>C (p.Ile353Thr)	single nucleotide variant	not specified [RCV004922389]	Chr13:99295088 [GRCh38] Chr13:99947342 [GRCh37] Chr13:13q32.3	uncertain significance
NM_004951.5(GPR183):c.966G>C (p.Met322Ile)	single nucleotide variant	not specified [RCV004922392]	Chr13:99295180 [GRCh38] Chr13:99947434 [GRCh37] Chr13:13q32.3	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	150
Count of miRNA genes:	135
Interacting mature miRNAs:	144
Transcripts:	ENST00000376414
Prediction methods:	Microtar, Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
2289426	BW213_H	Body weight QTL 213 (human)	2.78	0.0002	Body weight	BMI	13	84267977	110267977	Human
597386521	GWAS1482595_H	inflammatory bowel disease QTL GWAS1482595 (human)		0.000001	inflammatory bowel disease		13	99304368	99304369	Human
597376248	GWAS1472322_H	inflammatory bowel disease QTL GWAS1472322 (human)		2e-14	inflammatory bowel disease		13	99304368	99304369	Human
597070145	GWAS1166219_H	psoriasis QTL GWAS1166219 (human)		4e-08	psoriasis		13	99298006	99298007	Human
2289433	BW340_H	Body weight QTL 340 (human)	3.11		Body morphometry	waist circumference	13	84267977	110267977	Human
597465559	GWAS1561633_H	basal cell carcinoma QTL GWAS1561633 (human)		1e-08	basal cell carcinoma		13	99303544	99303545	Human

L08177

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	13	99,946,982 - 99,947,247	UniSTS	GRCh37
Build 36	13	98,744,983 - 98,745,248	RGD	NCBI36
Celera	13	80,790,546 - 80,790,811	RGD
Cytogenetic Map	13	q32.3	UniSTS
HuRef	13	80,541,362 - 80,541,627	UniSTS
Whitehead-YAC Contig Map	13		UniSTS

EBI2_25

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	13	99,946,723 - 99,947,431	UniSTS	GRCh37
Build 36	13	98,744,724 - 98,745,432	RGD	NCBI36
Celera	13	80,790,287 - 80,790,995	RGD
HuRef	13	80,541,103 - 80,541,811	UniSTS

G15934

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	13	99,946,799 - 99,947,004	UniSTS	GRCh37
Build 36	13	98,744,800 - 98,745,005	RGD	NCBI36
Celera	13	80,790,363 - 80,790,568	RGD
Cytogenetic Map	13	q32.3	UniSTS
HuRef	13	80,541,179 - 80,541,384	UniSTS

WI-18855

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	13	99,947,050 - 99,947,173	UniSTS	GRCh37
Build 36	13	98,745,051 - 98,745,174	RGD	NCBI36
Celera	13	80,790,614 - 80,790,737	RGD
Cytogenetic Map	13	q32.3	UniSTS
HuRef	13	80,541,430 - 80,541,553	UniSTS
GeneMap99-GB4 RH Map	13	282.82	UniSTS
Whitehead-RH Map	13	274.3	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2377	2788	2250	4854	1712	2238	4	614	1920	452	2179	7193	6426	30	3691	1	827	1685	1521	172	1


RefSeq Transcripts	NM_004951	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017020405	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AI740732	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK223390	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK292091	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK313443	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL160155	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AW402166	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AW574697	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AW575283	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC020752	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471085	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068265	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	JA738717	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	L08177	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000376414 ⟹ ENSP00000365596

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	13	99,294,539 - 99,307,399 (-)	Ensembl

RefSeq Acc Id:

NM_004951 ⟹ NP_004942

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	13	99,294,539 - 99,307,399 (-)	NCBI
GRCh37	13	99,946,789 - 99,959,749 (-)	RGD
Build 36	13	98,744,790 - 98,757,695 (-)	NCBI Archive
Celera	13	80,790,353 - 80,803,314 (-)	RGD
HuRef	13	80,541,169 - 80,554,130 (-)	ENTREZGENE
CHM1_1	13	99,916,965 - 99,929,926 (-)	NCBI
T2T-CHM13v2.0	13	98,504,775 - 98,517,640 (-)	NCBI

Sequence:

show sequence

ACTTCAGTTTGGACAACTACTCACAGCTACTACACAGAGACCCGAACGAGTCACTGATATACACCTGGACCACCACCAATGGATATACAAATGGCAAACAATTTTACTCCGCCCTCTGCAACTCCTCA
GGGAAATGACTGTGACCTCTATGCACATCACAGCACGGCCAGGATAGTAATGCCTCTGCATTACAGCCTCGTCTTCATCATTGGGCTCGTGGGAAACTTACTAGCCTTGGTCGTCATTGTTCAAAACA
GGAAAAAAATCAACTCTACCACCCTCTATTCAACAAATTTGGTGATTTCTGATATACTTTTTACCACCGCTTTGCCTACACGAATAGCCTACTATGCAATGGGCTTTGACTGGAGAATCGGAGATGCC
TTGTGTAGGATAACTGCGCTAGTGTTTTACATCAACACATATGCAGGTGTGAACTTTATGACCTGCCTGAGTATTGACCGCTTCATTGCTGTGGTGCACCCTCTACGCTACAACAAGATAAAAAGGAT
TGAACATGCAAAAGGCGTGTGCATATTTGTCTGGATTCTAGTATTTGCTCAGACACTCCCACTCCTCATCAACCCTATGTCAAAGCAGGAGGCTGAAAGGATTACATGCATGGAGTATCCAAACTTTG
AAGAAACTAAATCTCTTCCCTGGATTCTGCTTGGGGCATGTTTCATAGGATATGTACTTCCACTTATAATCATTCTCATCTGCTATTCTCAGATCTGCTGCAAACTCTTCAGAACTGCCAAACAAAAC
CCACTCACTGAGAAATCTGGTGTAAACAAAAAGGCTCTCAACACAATTATTCTTATTATTGTTGTGTTTGTTCTCTGTTTCACACCTTACCATGTTGCAATTATTCAACATATGATTAAGAAGCTTCG
TTTCTCTAATTTCCTGGAATGTAGCCAAAGACATTCGTTCCAGATTTCTCTGCACTTTACAGTATGCCTGATGAACTTCAATTGCTGCATGGACCCTTTTATCTACTTCTTTGCATGTAAAGGGTATA
AGAGAAAGGTTATGAGGATGCTGAAACGGCAAGTCAGTGTATCGATTTCTAGTGCTGTGAAGTCAGCCCCTGAAGAAAATTCACGTGAAATGACAGAAACGCAGATGATGATACATTCCAAGTCTTCA
AATGGAAAGTGAAATGGATTGTATTTTGGTTTATAGTGACGTAAACTGTATGACAAACTTTGCAGGACTTCCCTTATAAAGCAAAATAATTGTTCAGCTTCCAATTAGTATTCTTTTATATTTCTTTC
ATTGGGCACTTTCCCATCTCCAACTCGGAAGTAAGCCCAAGAGAACAACATAAAGCAAACAACATAAAGCACAATAAAAATGCAAATAAATATTTCATTTTTATTTGTAAACGAATACACCAAAAGGA
GGCGCTCTTAATAACTCCCAATGTAAAAAGTTTTGTTTTAATAAAAAATTTAATTATTATTTCTTGCCAACAAATGGCTAGAAAGGACTGAATAGATTATATATTGCCAGATGTTAATACTGTAACAT
ACTTTTTAAATAACATATTTCTTAAATCCAAATTTCTCTCAATGTTAGATTTAATTCCCTCAATAACACCAATGTTTTGTTTTGTTTCGTTCTGGGTCATAAAACTTTGTTAAGGAACTCTTTTGGAA
TAAAGAGCAGGATGCTGCAAA

hide sequence


Protein RefSeqs	NP_004942	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAA35924	(Get FASTA)	NCBI Sequence Viewer
	AAH20752	(Get FASTA)	NCBI Sequence Viewer
	BAD97110	(Get FASTA)	NCBI Sequence Viewer
	BAF84780	(Get FASTA)	NCBI Sequence Viewer
	BAG36232	(Get FASTA)	NCBI Sequence Viewer
	CCF77011	(Get FASTA)	NCBI Sequence Viewer
	EAX09018	(Get FASTA)	NCBI Sequence Viewer
	EAX09019	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000365596
	ENSP00000365596.4
GenBank Protein	P32249	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:

NP_004942 ⟸ NM_004951

- UniProtKB:

Q53F99 (UniProtKB/Swiss-Prot), B2R8N5 (UniProtKB/Swiss-Prot), Q5JUH7 (UniProtKB/Swiss-Prot), P32249 (UniProtKB/Swiss-Prot)

- Sequence:

show sequence

MDIQMANNFTPPSATPQGNDCDLYAHHSTARIVMPLHYSLVFIIGLVGNLLALVVIVQNRKKINSTTLYSTNLVISDILFTTALPTRIAYYAMGFDWRIGDALCRITALVFYINTYAGVNFMTCLSID
RFIAVVHPLRYNKIKRIEHAKGVCIFVWILVFAQTLPLLINPMSKQEAERITCMEYPNFEETKSLPWILLGACFIGYVLPLIIILICYSQICCKLFRTAKQNPLTEKSGVNKKALNTIILIIVVFVLC
FTPYHVAIIQHMIKKLRFSNFLECSQRHSFQISLHFTVCLMNFNCCMDPFIYFFACKGYKRKVMRMLKRQVSVSISSAVKSAPEENSREMTETQMMIHSKSSNGK

hide sequence

Ensembl Acc Id:

ENSP00000365596 ⟸ ENST00000376414

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-P32249-F1-model_v2	AlphaFold	P32249	1-361	view protein structure

RGD ID:

6790892

Promoter ID:

HG_KWN:18390

Type:

Non-CpG

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, CD4+TCell_12Hour, K562, Lymphoblastoid

Transcripts:

UC010AFX.1

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	13	98,745,341 - 98,747,147 (-)	MPROMDB

RGD ID:

6790893

Promoter ID:

HG_KWN:18391

Type:

Non-CpG

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, K562, Lymphoblastoid

Transcripts:

OTTHUMT00000045582

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	13	98,757,596 - 98,758,647 (-)	MPROMDB

RGD ID:

7226725

Promoter ID:

EPDNEW_H19105

Type:

initiation region

Name:

GPR183_1

Description:

G protein-coupled receptor 183

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	13	99,307,398 - 99,307,458	EPDNEW

Database	Acc Id	Source(s)
COSMIC	GPR183	COSMIC
Ensembl Genes	ENSG00000169508	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000376414	ENTREZGENE
	ENST00000376414.5	UniProtKB/Swiss-Prot
Gene3D-CATH	Rhodopsin 7-helix transmembrane proteins	UniProtKB/Swiss-Prot
GTEx	ENSG00000169508	GTEx
HGNC ID	HGNC:3128	ENTREZGENE
Human Proteome Map	GPR183	Human Proteome Map
InterPro	GP183-like	UniProtKB/Swiss-Prot
	GPCR_Rhodpsn	UniProtKB/Swiss-Prot
	GPCR_Rhodpsn_7TM	UniProtKB/Swiss-Prot
KEGG Report	hsa:1880	UniProtKB/Swiss-Prot
NCBI Gene	1880	ENTREZGENE
OMIM	605741	OMIM
PANTHER	G-PROTEIN COUPLED RECEPTOR	UniProtKB/Swiss-Prot
	G-PROTEIN COUPLED RECEPTOR 183	UniProtKB/Swiss-Prot
Pfam	7tm_1	UniProtKB/Swiss-Prot
PharmGKB	PA162390174	PharmGKB
PRINTS	GPCRRHODOPSN	UniProtKB/Swiss-Prot
	P2YPURNOCPTR	UniProtKB/Swiss-Prot
PROSITE	G_PROTEIN_RECEP_F1_1	UniProtKB/Swiss-Prot
	G_PROTEIN_RECEP_F1_2	UniProtKB/Swiss-Prot
SMART	7TM_GPCR_Srsx	UniProtKB/Swiss-Prot
Superfamily-SCOP	Family A G protein-coupled receptor-like	UniProtKB/Swiss-Prot
UniProt	B2R8N5	ENTREZGENE
	GP183_HUMAN	UniProtKB/Swiss-Prot, ENTREZGENE
	Q53F99	ENTREZGENE
	Q5JUH7	ENTREZGENE
UniProt Secondary	B2R8N5	UniProtKB/Swiss-Prot
	Q53F99	UniProtKB/Swiss-Prot
	Q5JUH7	UniProtKB/Swiss-Prot

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Imported Disease Annotations - ClinVar

Imported Disease Annotations - CTD

Imported Human Phenotype Annotations - ClinVar

Send us a Message

Imported Disease Annotations - ClinVar

Imported Disease Annotations - CTD

Imported Human Phenotype Annotations - ClinVar